Truist downgrades Nike to Sell, says rally ignores ongoing risks

Truist downgraded Nike to Sell while maintaining its $29 price target, saying the stock’s 19% rally over roughly a month was driven by sector rotation rather than better fundamentals. Nike trades at 27 times earnings two years out, almost double the peer average; five of seven recent Nike and Jordan launches sold below retail price, while Truist sees pressure in Sportswear, running and China. The firm cut its fiscal 2028 EPS estimate to $1.30, below the Street’s $1.50.

Analysis

The key risk is not simply weaker demand; it is a mix shift and pricing-quality problem. If core franchises need sustained discounting, Nike could lose both gross-margin leverage and the brand scarcity that supports full-price sell-through. That raises the possibility that earnings estimates fall faster than revenue, while a premium multiple leaves the shares exposed to estimate cuts and multiple compression. Competitors such as Adidas, On, and Deckers’ Hoka could benefit if consumers switch, but sustained share gains need confirmation in sell-through rather than launch anecdotes.

Near term, the rally creates asymmetric downside if upcoming results or guidance fail to validate a China or running recovery. Over 1–3 months, watch full-price sell-through, markdown intensity, China demand commentary, and inventory; over 6–18 months, the question is whether product refreshes restore pricing power or whether discounting becomes the mechanism for clearing supply. The World Cup comparison is a temporary hurdle, not by itself evidence of structural weakness.

Contrarian check: the downgrade and lower estimate may already have raised investor caution, so a short based only on the note risks chasing a crowded narrative. The more consequential signal would be company-level evidence that markdowns are broadening or that guidance resets again. The thesis weakens if Nike demonstrates improving full-price sales and inventory discipline, particularly in China and Sportswear.

Key Decisions for Investors

• Avoid adding to NKE on momentum alone; treat the recent outperformance as vulnerable until results show improving full-price sell-through and China stabilization.
• For a defined-risk bearish expression, consider a put spread around the next earnings catalyst rather than an outright short; size for the possibility that weak expectations are already reflected. No price target is warranted from the supplied data.
• Watch Nike’s inventory, markdowns, and regional guidance at the next report. A further guidance reduction or broader discounting would strengthen the downside case; improving sell-through without promotional support would invalidate it.
• Do not yet assume Adidas, On, or Hoka have captured durable share. Consider relative exposure only after independent sell-through or market-share evidence confirms substitution.